Margo Georgiadis is a CEO-partner at Flagship Pioneering and co-founder and CEO of Montai Health, an AI platform company enabling the predictable discovery of breakthrough small molecule medicines to treat and preempt chronic disease. In these roles, Georgiadis brings extensive expertise in technological innovation and high-performance business transformation and leverages her artificial intelligence and machine learning experience to advance biotech innovation. In this presentation and conversation with Stanford adjunct lecturer Ravi Belani, Georgiadis shares frameworks that Flagship uses to develop deep tech companies and her approach to addressing the challenges of drug discovery.
Podden och tillhörande omslagsbild på den här sidan tillhör Stanford eCorner. Innehållet i podden är skapat av Stanford eCorner och inte av, eller tillsammans med, Poddtoppen.
